Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. septic shock
Show results for
Products
Services
Software
Applications

Companies

News
Articles
Downloads

Refine by
Date

  • Older

Septic Shock Articles & Analysis

14 news found

Biocartis Announces Presentation of Three Idylla™ Studies at 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID)

Biocartis Announces Presentation of Three Idylla™ Studies at 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID)

From eight patients diagnosed with either septic shock or sepsis, six had elevated scores and two had intermediate-elevated scores. ...

ByBiocartis NV


SafeHeal Announces Successful Launch of IDE Study for Colovac Endoluminal Bypass Sheath

SafeHeal Announces Successful Launch of IDE Study for Colovac Endoluminal Bypass Sheath

It is one of the most serious complications of colorectal surgery, frequently resulting in the rapid development of severe peritonitis, septic shock, multiple organ dysfunction, and potential mortality. ...

BySafeHeal


Daxor Announces Key Milestones Achieved for Multicenter BVA-100 Study in Hospitalized Patients With COVID-19

Daxor Announces Key Milestones Achieved for Multicenter BVA-100 Study in Hospitalized Patients With COVID-19

In a randomized control trial (RCT) published in 2011 in the journal Shock, patients at a Level-1 trauma center ICU suffering predominantly from ARDS/sepsis/septic shock/hemorrhagic shock who received BVA-guided care showed significant benefits including a 66% lower mortality rate (P Analysis showed 44% of BVA test results led ...

ByDaxor Corporation


Daxor Announces Key Milestones Achieved for Multicenter Bva-100® Study In Hospitalized Patients With Covid-19

Daxor Announces Key Milestones Achieved for Multicenter Bva-100® Study In Hospitalized Patients With Covid-19

In a randomized control trial (RCT) published in 2011 in the journal Shock, patients ata Level-1 trauma center ICU suffering predominantly from ARDS/sepsis/septic shock/hemorrhagic shock who received BVA-guided care showed significant benefits including a 66% lower mortality rate ...

ByDaxor Corporation


Imbed Biosciences Wins a $2M Award From the U.S. Army to Prevent Combat Wound Infections

Imbed Biosciences Wins a $2M Award From the U.S. Army to Prevent Combat Wound Infections

“Combat wounds are contaminated with bacteria that start forming biofilms within hours of injury and can lead to failure of treatment, septic shock, and death”, said Ankit Agarwal, co-founder and CEO of the company. ...

ByImbed Biosciences


New Research Demonstrates Clinical Utility of Daxor Corporation Blood Volume (BVA-100) Diagnostic in Neurocritical Care

New Research Demonstrates Clinical Utility of Daxor Corporation Blood Volume (BVA-100) Diagnostic in Neurocritical Care

In a randomized control trial (RCT) published in the journal Shock, the BVA-100 test has shown to reduce ICU mortality by 66% (P=0.03) and reduce ventilator days in patients suffering predominantly from acute respiratory distress syndrome and septic shock. ...

ByDaxor Corporation


Cytovale Begins Enrollment in FDA 510(k) Clinical Validation Study of IntelliSep Rapid Sepsis Test

Cytovale Begins Enrollment in FDA 510(k) Clinical Validation Study of IntelliSep Rapid Sepsis Test

The condition is the no. 1 cause of death in hospitals, taking the lives of 270,000 people every year in the U.S. alone – more than opioid overdoses, prostate cancer, and breast cancer combined.1 Mortality from sepsis increases as much as eight percent with every hour of delayed treatment, and as many as 80 percent of septic shock patients survive with ...

ByCytovale Inc.


Cytovale Receives Distinguished Abstract Award from AACC for Evaluation of Sepsis Assay

Cytovale Receives Distinguished Abstract Award from AACC for Evaluation of Sepsis Assay

Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34(6):1589-1596. 3. Torio C, Moore B. ...

ByCytovale Inc.


New respiratory multitest

New respiratory multitest

Clinically, patients with SARS-Cov-2 infection tend to suffer from mile symptoms such as fever, dry cough, anosmia, fatigue, dyspnea, headache, diarrhea, and sore throat followed by vascular and systemic complications such as leukocyte infiltration of the lungs, pneumonia, severe pneumonia, severe acute respiratory diseases syndrome (ARDS), sepsis and septic ...

ByVitassay Healthcare, S.L.U.


Thermo Fisher Scientific Supports Sepsis Awareness Month in September

Thermo Fisher Scientific Supports Sepsis Awareness Month in September

The results of the assay are intended to aid in: assessing the risk of critically ill patients on their first day of intensive care unit (ICU) admission for progression to severe sepsis and septic shock; determining the change in PCT level over time as an aid in assessing the cumulative 28-day risk of all-cause mortality for patients diagnosed with severe ...

ByThermo Fisher Scientific, LIMS & Laboratory Software


SafeHeal obtains CE-mark for Colovac, its novel endoluminal bypass sheath

SafeHeal obtains CE-mark for Colovac, its novel endoluminal bypass sheath

It is considered to be the most serious colorectal surgical complication, frequently resulting in the rapid development of severe peritonitis, septic shock and multiple organ dysfunction. This leads to increased mortality rates. ...

BySafeHeal


SafeHeal Completes First-in-Human Clinical Study of Endoluminal Bypass Sheath

SafeHeal Completes First-in-Human Clinical Study of Endoluminal Bypass Sheath

It is considered to be the most serious colorectal surgical complication, frequently resulting in the rapid development of severe peritonitis, septic shock and multiple organ dysfunction. This leads to increased mortality rates. ...

BySafeHeal


Abionic Successfully Raises CHF20 Million in Series C Financing

Abionic Successfully Raises CHF20 Million in Series C Financing

” Starting in April 2018, the international sepsis impact study will evaluate the efficacy of the PSP test to help clinicians to identify sepsis earlier and better manage patients at risk of sepsis and septic shock in over 300 patients in 14 ICU sites in Switzerland, Italy, France and the UK. ...

ByAbionic SA


SAFEHEAL starts first-in-human and CE-mark clinical study of endoluminal bypass sheath with the potential of replacing ostomy

SAFEHEAL starts first-in-human and CE-mark clinical study of endoluminal bypass sheath with the potential of replacing ostomy

It is considered to be the most serious colorectal surgical complication, frequently resulting in the rapid development of severe peritonitis, septic shock and multiple organ dysfunction. This leads to increased mortality rates. ...

BySafeHeal

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT